tiprankstipranks
Advertisement
Advertisement
Eli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344
PremiumRatingsEli Lilly Buy Rating Reiterated on Durable Incretin and Obesity Growth, Price Target Maintained at $1,344
7d ago
Psychedelic: Enveric, Helus, Bright Minds report earnings results
Premium
The Fly
Psychedelic: Enveric, Helus, Bright Minds report earnings results
8d ago
Novo Nordisk testing lower doses of oral Wegovy, Reuters reports
Premium
The Fly
Novo Nordisk testing lower doses of oral Wegovy, Reuters reports
9d ago
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
PremiumThe FlyPsychedelic: Definium’s LSD-based pill meets endpoints in GAD study
11d ago
Cboe data shows mixed options sentiment in Eli Lilly with shareslittle changed
Premium
The Fly
Cboe data shows mixed options sentiment in Eli Lilly with shareslittle changed
11d ago
Bristol Gate’s Richard Hamm Trims Eli Lilly Stake
Premium
Company Announcements
Bristol Gate’s Richard Hamm Trims Eli Lilly Stake
13d ago
ARK Investment’s Cathie Wood boosts Eli Lilly stake 64,578 shares
PremiumCompany AnnouncementsARK Investment’s Cathie Wood boosts Eli Lilly stake 64,578 shares
13d ago
Graham Capital boosts Eli Lilly stake with 1,736 shares
Premium
Company Announcements
Graham Capital boosts Eli Lilly stake with 1,736 shares
13d ago
Glenview Capital Boosts Eli Lilly Stake by 57,771 Shares
Premium
Company Announcements
Glenview Capital Boosts Eli Lilly Stake by 57,771 Shares
13d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100